2012
Is port site resection necessary in the surgical management of gallbladder cancer?, Ajay V Maker, Jean M Butte, Jacqueline Oxenberg DO, Deborah Kuk, Mithat Gonen, Yuman Fong, Ronald P Dematteo, Michael I D'Angelica, Peter J Allen, and William R Jarnagin (Article)
Simultaneous peripheral facial palsies (SPFP) and bilateral foot drops after initiation of eribulin in a patient with triple-negative breast cancer., Tara Morrison MD, R F. Swaby, P D. Ryan, and P Ambady (Article)
Immunotherapy of cancer: reprogramming tumor-immune crosstalk., Kyle K Payne, Amir Toor MD, Xiang-Yang Wang, and Masoud H Manjili (Article)
Single-cell pharmacodynamic monitoring of S6 ribosomal protein phosphorylation in AML blasts during a clinical trial combining the mTOR inhibitor sirolimus and intensive chemotherapy., Alexander E Perl, Margaret T Kasner, Doris Shank, Selina M Luger, and Martin Carroll (Article)
Anti-thymocyte globulin for conditioning in matched unrelated donor hematopoietic cell transplantation provides comparable outcomes to matched related donor recipients., D A Portier, R T Sabo, C H Roberts, D S Fletcher, J Meier, W B Clark, M C Neale, M H Manjili, J M McCarty, H M Chung, and Amir Toor MD (Article)
Community Cancer Services, Clinical Trials, and Quality Initiatives--Year 2 NCCCP at Lehigh Valley Health Network, Ada M. Rivera BA; Lenore A. McGonigle Ms; MaryEllen Shiels BS; Smiyyah Q. Whitney RN; Suresh G. Nair MD; Janelle M. Sharma; Kathy Sevedge RN, MA, AOCN; Eliot L. Friedman MD; Nadesda Mack RN, BSN, MBA, OCN; and Gregory R. Harper MD, PhD (Poster)
Are low-intensity induction strategies better for older patients with acute myeloid leukemia?, Gail J Roboz; Usama Wissa; Ellen K Ritchie; Usama Gergis MD, MBA; Sebastian Mayer; Joseph M Scandura; Paul J Christos; and Eric J Feldman (Article)
Neoadjuvant ipilimumab in locally/regionally advanced melanoma: Clinical outcome and immune monitoring, Saro Sarkisian MD (Article)
PTEN gene expression and mutations in the PIK3CA gene as predictors of clinical benefit to anti-epidermal growth factor receptor antibody therapy in patients with KRAS wild-type metastatic colorectal cancer., Arjun Sood, Danielle McClain, Radhashree Maitra, Atrayee Basu-Mallick, Raviraja Seetharam, Andreas Kaubisch, Lakshmi Rajdev, John M Mariadason, Kathryn Tanaka, and Sanjay Goel (Article)
Management of locally advanced non-small cell lung cancer (NSCLC) at a community hospital: A retrospective analysis., Laura Spranklin DO, J W. Heflin, and A R. Calvo (Article)
Perceived levels of pain associated with bone marrow aspirates and biopsies., Giampaolo Talamo, Jason Liao, Jamal Joudeh, Nicholas Lamparella DO, Hoang Dinh, Jozef Malysz, and W Christopher Ehmann (Article)
Phase II clinical and pharmacokinetic study of aflibercept in patients with previously treated metastatic colorectal cancer., Patricia A Tang, Steven J Cohen, Christian Kollmannsberger, Georg Bjarnason, Kiran Virik, Mary J MacKenzie, Lillian Lourenco, Lisa Wang, Alice Chen, and Malcolm J Moore (Article)
Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines., Margaret A Tempero, J Pablo Arnoletti, Stephen W Behrman, Edgar Ben-Josef, Al B Benson, Ephraim S Casper, Steven J Cohen, Brian Czito, Joshua D I Ellenhorn, William G Hawkins, Joseph Herman, John P Hoffman, Andrew Ko, Srinadh Komanduri, Albert Koong, Wen Wee Ma, Mokenge P Malafa, Nipun B Merchant, Sean J Mulvihill, Peter Muscarella, Eric K Nakakura, Jorge Obando, Martha B Pitman, Aaron R Sasson, Anitra Tally, Sarah P Thayer, Samuel Whiting, Robert A Wolff, Brian M Wolpin, Deborah A Freedman-Cass, and Dorothy A Shead (Article)
Epigenetic induction of adaptive immune response in multiple myeloma: sequential azacitidine and lenalidomide generate cancer testis antigen-specific cellular immunity., Amir Toor MD, Kyle K Payne, Harold M Chung, Roy T Sabo, Allison F Hazlett, Maciej Kmieciak, Kimberly Sanford, David C Williams, William B Clark, Catherine H Roberts, John M McCarty, and Masoud H Manjili (Article)
Favorable outcomes in patients with high donor-derived T cell count after in vivo T cell-depleted reduced-intensity allogeneic stem cell transplantation., Amir Toor MD, Roy T Sabo, Harold M Chung, Catherine Roberts, Rose H Manjili, Shiyu Song, David C Williams, Wendy Edmiston, Mandy L Gatesman, Richard W Edwards, Andrea Ferreira-Gonzalez, William B Clark, Michael C Neale, John M McCarty, and Masoud H Manjili (Article)
ACE inhibitor-induced angioedema., Monali Vasekar and Timothy J Craig (Article)
2011
Transformation of the 5q- Syndrome to Acute Lymphoblastic Leukemia: A Report of Two Cases and Review of the Literature, Nicole M. Agostino DO, Basil Ahmed MD, Dan Popescu MD, and Shereen M. Gheith MD (Article)
Effect of the Tyrosine Kinase Inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on Blood Glucose Levels in Diabetic and Nondiabetic Patients in General Clinical Practice, Nicole M. Agostino DO; Vernon M. Chinchilli PhD; Christopher J. Lynch PhD; Anita M. Koszyk-Szewczyk MD; Rebecca Gingrich RN, MS, OCN; Jeffrey Sivik D Pharma; and Joseph J. Drabick MD, FACP (Article)
Phase II and coagulation cascade biomarker study of bevacizumab with or without docetaxel in patients with previously treated metastatic pancreatic adenocarcinoma., Igor A Astsaturov, Neal J Meropol, R Katherine Alpaugh, Barbara A Burtness, Jonathan D Cheng, Sue McLaughlin, André Rogatko, Zhiheng Xu, James C Watson, Louis M Weiner, and Steven J Cohen (Article)
Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker senicapoc (ICA-17043)., Kenneth I Ataga, Marvin Reid, Samir K Ballas, Zahida Yasin, Carolyn Bigelow, Luther St James, Wally R Smith, Frederic Galacteros, Abdullah Kutlar, James H Hull, Jonathan W Stocker, and Maged Khalil MD (Article)
High throughput sequencing technology (Sequenom) as a tool to detect SNPs in human metastatic colorectal cancer (mCRC) and cell lines, A Basu Mallick (Article)
Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyroid cancer., Marcia S Brose, Christopher M Nutting, Steven I Sherman, Young Kee Shong, Johannes W A Smit, Gerhard Reike, John Chung, Joachim Kalmus, Christian Kappeler, and Martin Schlumberger (Article)
Significance of pathologic response to preoperative therapy in pancreatic cancer., Yun Shin Chun, Harry S Cooper, Steven J Cohen, Andre Konski, Barbara Burtness, Crystal S Denlinger, Igor Astsaturov, Michael J Hall, and John P Hoffman (Article)
Neuroticism Influences Brain Activity During the Experience of Visceral Pain, S J. Cohen (Article)
Targeted inhibition of CD133+ cells in oral cancer cell lines., M Damek-Poprawa, A Volgina, J Korostoff, T P Sollecito, M S Brose, B W O'Malley, S O Akintoye, and J M DiRienzo (Article)
Large vocal fold polyp., Venu Divi, Robert T Sataloff, and Jacqueline Oxenberg DO (Article)
Challenges in the management of stage II colon cancer., Efrat Dotan and Steven J Cohen (Article)
A Database Developed with Information Extracted from Chemotherapy Drug Package Inserts to Enhance Future Prescriptions., Malcolm J D'Souza; Ghada J Alabed; Jordan M Wheatley; Natalia Roberts; Yogasudha Veturi; Xia Bi MD, MS; and Christopher Hart Continisio (Article)
A 2 Step Approach to Myeloablative Haploidentical Hematopoietic Stem Cell Transplanation (HSCT): Report of a Phase II Trial With 18 Months of Follow-Up for All Patients, Joanne Filicko-O'Hara (Article)
Absolute Lymphocyte Count As Predictor of Survival Following Hematopoietic Stem Cell Transplants, Joanne Filicko-O'Hara (Article)
HLA Disparity and Rapid Immune Reconstitution Do Not Overcome Propensity to Relapse in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant (HSCT) With Persistent Disease at the Time of Transplant, Joanne Filicko-O'Hara (Article)
L-Leucyl-L-Leucine Methyl Ester (LLME) Treated Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Patients With Hematological Malignancies, Joanne Filicko-O'Hara (Article)
Mid-term Analysis of IIIA NSCLC Patients Treated With Neoadjuvant Chemoradiation Followed by Surgical Resection, Eliot L. Friedman MD (Presentation)
Neo-adjuvant Chemotherapy and Radiation Therapy in Patients with Stage IIIA (N2) Non-Small Cell Lung Cancer (NSCLC): A Retrospective Analysis with Lessons Learned, Eliot L. Friedman MD, Michael F. Szwerc MD, Charles Andrews MD, Robert Kruklitis MD, Kathleen A. Leies, and Ferdy Santiago (Poster)
Autologous hematopoietic stem-cell transplantation in combination with thalidomide as treatment for histiocytic sarcoma: a case report and review of the literature., Usama Gergis MD, MBA; Hendrik Dax; Ellen Ritchie; Rachel Marcus; Usama Wissa; and Attilio Orazi (Article)
PRKN, DJ-1, and PINK1 screening identifies novel splice site mutation in PRKN and two novel DJ-1 mutations., Farzaneh Ghazavi, Zeinab Fazlali, Setareh Sadat Banihosseini, Sayed-Rzgar Hosseini, Mohammad Hossein Kazemi MD, Seyedmehdi Shojaee, Khosro Parsa, Homa Sadeghi, Farzad Sina, Mohammad Rohani, Gholam-Ali Shahidi, Nasser Ghaemi, Mostafa Ronaghi, and Elahe Elahi (Article)
Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN): Analysis of disparities in care., Michael Greenberg (Article)
A 2-step approach to myeloablative haploidentical stem cell transplantation: a phase 1/2 trial performed with optimized T-cell dosing., Dolores Grosso, Matthew Carabasi, Joanne Filicko-O'Hara, Margaret Kasner, John L Wagner, Beth Colombe, Patricia Cornett Farley, William O'Hara, Phyllis Flomenberg, Maria Werner-Wasik, Janet Brunner, Bijoyesh Mookerjee, Terry Hyslop, Mark Weiss, and Neal Flomenberg (Article)
Treatment of advanced pancreatic carcinoma with 90Y-Clivatuzumab Tetraxetan: a phase I single-dose escalation trial., Seza A Gulec, Steven J Cohen, Kenneth L Pennington, Lionel S Zuckier, Ralph J Hauke, Heather Horne, William A Wegener, Nick Teoh, David V Gold, Robert M Sharkey, and David M Goldenberg (Article)
Emerging therapies for advanced gastroenteropancreatic neuroendocrine tumors., Sameer Gupta, Paul F Engstrom, and Steven J Cohen (Article)
Community Cancer Services, Clinical Trials, and Quality Initiatives—Year 1 NCCCP at Lehigh Valley Health Network, Gregory R. Harper MD, PhD; Ada M. Rivera BA; Eliot L. Friedman MD; Kathleen A. Leies RN, OCN; Nadesda Mack RN, BSN, MBA, OCN; Lenore McGonigle Med; Suresh G. Nair MD; Tara Namey MS, CGC; Debbie Salas-Lopez MD, MPH, FACP; and Ronald W. Swinfard MD, FACP (Poster)
Single-Cell Pharmacodynamic Monitoring of S6 Ribosomal Protein in AML Blasts During Trials Combining Sirolimus and Intensive Chemotherapy: Target Inhibition Enhances Response, M Kasner (Article)
Activated NKT cells and NK cells render T cells resistant to myeloid-derived suppressor cells and result in an effective adoptive cellular therapy against breast cancer in the FVBN202 transgenic mouse., Maciej Kmieciak, Debasmita Basu, Kyle K Payne, Amir Toor MD, Adly Yacoub, Xiang-Yang Wang, Lisa Smith, Harry D Bear, and Masoud H Manjili (Article)
Ex vivo expansion of tumor-reactive T cells by means of bryostatin 1/ionomycin and the common gamma chain cytokines formulation., Maciej Kmieciak, Amir Toor MD, Laura Graham, Harry D Bear, and Masoud H Manjili (Article)
Future directions in the treatment of neuroendocrine tumors: consensus report of the National Cancer Institute Neuroendocrine Tumor clinical trials planning meeting., Matthew H Kulke, Lillian L Siu, Joel E Tepper, George Fisher, Deborah Jaffe, Daniel G Haller, Lee M Ellis, Jacqueline K Benedetti, Emily K Bergsland, Timothy J Hobday, Eric Van Cutsem, James Pingpank, Kjell Oberg, Steven J Cohen, Mitchell C Posner, and James C Yao (Article)
Comment on "Cutting edge: CD8+ T cell priming in the absence of NK cells leads to enhanced memory responses"., Masoud H Manjili and Amir Toor MD (Article)
Exploring therapeutic decisions in elderly patients with non-small cell lung cancer: results and conclusions from North Central Cancer Treatment Group Study N0222., Heidi Mc Kean, Philip J Stella, Shauna L Hillman, Kendrith M Rowland, Michael W Cannon, Robert J Behrens, Gerald G Gross, Mark D Sborov, Eliot L. Friedman MD, and Aminah Jatoi (Article)
Early success in narrowing age, gender, and racial disparities in clinical trial accrual: Targeted screening efforts through the National Cancer Institute Community Cancer Centers Program (NCCCP)., Suresh G. Nair MD (Article)
Influence of KRAS and BRAF mutational status and rash on disease-free survival (DFS) in patients with resected stage III colon cancer receiving cetuximab (Cmab): Results from NCCTG N0147., Suresh G. Nair MD (Article)
Pilot experience with adjuvant FOLFIRI with or without cetuximab in patients with resected stage III colon cancer: NCCTG Intergroup N0147., Suresh G. Nair MD (Article)
Quality of life (QOL) for patients treated with FOLFOX with or without cetuximab (Cmab) following complete resection of colorectal cancer (CRC): Results from North Central Cancer Treatment Group (NCCTG) phase III trial N0147, Suresh G. Nair MD (Article)
The RET/PTC3 oncogene activates classical NF-κB by stabilizing NIK., R J Neely, M S Brose, C M Gray, K A McCorkell, J M Leibowitz, C Ma, J L Rothstein, and M J May (Article)
Assessing compliance with national comprehensive cancer network guidelines for elderly patients with stage III colon cancer: the Fox Chase Cancer Center Partners' initiative., Margaret A O'Grady, Elyse Slater, Elin R Sigurdson, Neal J Meropol, Alan Weinstein, Charles J Lusch, Elaine Sein, Patricia Keeley, Bonnie Miller, Paul F Engstrom, and Steven J Cohen (Article)
Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML., Joseph M Scandura; Gail J Roboz; Michelle Moh; Ewelina Morawa; Fabienne Brenet; J Robi Bose; Luis Villegas; Usama Gergis MD, MBA; Sebastian A Mayer; Cindy M Ippoliti; Tania J Curcio; Ellen K Ritchie; and Eric J Feldman (Article)
Decreased Posttreatment SUV on PET Scan Is Associated With Improved Local Control in Medically Inoperable Esophageal Cancer., Navesh K Sharma, Joshua S Silverman, Tianyu Li, Jonathan Cheng, Jian Q Yu, Oleh Haluszka, Walter Scott, Neal J Meropol, Steven J Cohen, Gary M Freedman, and Andre A Konski (Article)
Chronic lymphocytic leukemia/small lymphocytic lymphoma with pancytopenia and chylothorax., Lisa C Thomas, Matthew J Maida, Ubaldo Martinez-Outschoorn, Joanne Filicko-O'Hara, and Gloria J Morris (Article)
2010
Effect of the Tyrosine Kinase Inhibitors (Sunitinib, Sorafenib, Dasatinib, and Imatinib) on Blood Glucose Levels in Diabetic and Non-diabetic Patients in General Clinical Practice (Poster), Nicole M. Agostino DO; Vernon M. Chinchilli PhD; Christopher J. Lynch PhD; Anita M. Koszyk-Szewczyk MD; Rebecca Gingrich RN, MS, OCN; Jeffery Sivik D Pharma; and Joseph J. Darbick MD, FACP (Poster)
Bevacizumab Demonstrates Prolonged Disease Stabilization in Patients with Heavily Pretreated Metastatic Renal Cell Carcinoma: A Case Series and Review of the Literature, Nicole M. Agostino DO and Rebecca Gingrich (Article)
The role of CD40L and VEGF in the modulation of angiogenesis and inflammation., Subrata Chakrabarti, Muhammad A. Rizvi MD, Kristine Morin, Ravi Garg, and Jane E Freedman (Article)
Defining venous involvement in borderline resectable pancreatic cancer., Yun Shin Chun, Barton N Milestone, James C Watson, Steven J Cohen, Barbara Burtness, Paul F Engstrom, Oleh Haluszka, Jeffrey L Tokar, Michael J Hall, Crystal S Denlinger, Igor Astsaturov, and John P Hoffman (Article)
A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer., Steven J Cohen, Mark M Zalupski, Manuel R Modiano, Paul Conkling, Yehuda Z Patt, Peg Davis, Robert T Dorr, Michelle L Boytim, and Evan M Hersh (Article)
Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas., Margaret J Dougherty, Mariarita Santi, Marcia S Brose, Changqing Ma, Adam C Resnick, Angela J Sievert, Phillip B Storm, and Jaclyn A Biegel (Article)
A Front-Line Window of Opportunity Phase 2 Study of Sorafenib in Patients with Advanced Nonsmall Cell Lung Cancer: North Central Cancer Treatment Group Study N0326., Grace K. Dy, Shauna L. Hillman, Kendrith M. Rowland, Julian R. Molina, Preston D. Steen MD, Donald B. Wender, Suresh G. Nair MD, Sumithra Mandrekar, Steven E. Schild, and Alex A. Adjei (Article)
Presentation, Treatment, and Outcome for Twenty Consecutive Patients with Human Immunodeficiency Virus (HIV) Associated Thrombotic Microangiopathies (TMA), Michael W. Evans MD, MPH (Article)
Rituximab treatment for thrombotic thrombocytopenic purpura associated with human immunodeficiency virus failing extensive treatment with plasma exchange: a report of two cases., Michael W. Evans MD, MPH; Leroy B Vaughan; Victoria S Giffi; Ann B Zimrin; and John R Hess (Article)
Phase II Study of Bortezomib, Mitoxantrone and Etoposide In Relapsed/ Refractory Acute Leukemias, Joanne Filicko-O'Hara (Article)
Haploidentical Transplantation In Adults ≥ 66 Years of Age, Joanne Filicko-O'Hara and William O'Hara (Article)
Multidisciplinary Survivorship Care, Sue N. Gardner RN, MSN, CRNP, AOCNP; Gregory Harper MD, PhD; Dorothy Morrone RNC, MS, OCN; Jennifer Brennan RD, CSO; Andrea Geshan RN, MSW; Diane Brong LCSW; and Jennifer Roeder MSPT, MBA (Poster)
Randomized phase III trial of pegfilgrastim versus filgrastim after autologus peripheral blood stem cell transplantation., Aaron Gerds, Mary Fox-Geiman, Kevin Dawravoo, Tulio Rodriguez, Amir Toor MD, Scott Smith, Karen Kiley, Donna Fletcher-Gonzalez, Chindo Hicks, and Patrick Stiff (Article)
Effectiveness and safety of tocilizumab, an anti-interleukin-6 receptor monoclonal antibody, in a patient with refractory GI graft-versus-host disease., Usama Gergis MD, MBA; Jon Arnason; Rhonda Yantiss; Tsiporah Shore; Usama Wissa; Eric Feldman; and Thasia Woodworth (Article)
Voriconazole provides effective prophylaxis for invasive fungal infection in patients receiving glucocorticoid therapy for GVHD., Usama Gergis MD, MBA; K Markey; J Greene; M Kharfan-Dabaja; T Field; G Wetzstein; M J Schell; Y Huang; C Anasetti; and J Perkins (Article)
High-risk myelodysplastic syndromes: chemotherapy, transplantation, and beyond., Usama Gergis MD, MBA and Usama Wissa (Article)
Primary Merkel cell carcinoma of the parotid gland., Mahmoud Ghaderi, Jeffrey Coury, Jacqueline Oxenberg DO, and Harvey Spector (Article)
Cancer: The Lived Experience of Patients and Families, Lorraine Gyauch MA, RN,CT, CGS (Presentation)
Phase I clinical trial of the chimeric anti-mesothelin monoclonal antibody MORAb-009 in patients with mesothelin-expressing cancers., Raffit Hassan, Steven J Cohen, Martin Phillips, Ira Pastan, Elad Sharon, Ronan J Kelly, Charles Schweizer, Susan Weil, and Daniel Laheru (Article)
Novel targets for treatment of adult acute lymphocytic leukemia., Margaret T Kasner (Article)
Targeting vascular endothelial growth factor receptor in thyroid cancer: the intracellular and extracellular implications., Stephen M Keefe, Marc A Cohen, and Marcia S Brose (Article)
Incorporating Rehabilitation Services into Oncology Site-specific Clinical Practice Guidelines, Kathleen Leies RN, OCN; Kathy Sevedge RN, MA, AOCN; Dorothy Morrone RNC, MS, OCN; Stephanie Marshall CCER; and Jennifer Roeder MSPT, MBA (Poster)
Steroid hormones drive cancer development, S V. Madhunapantula, Paul Mosca, and G P. Robertson (Article)
Diet Index-Based and Empirically Derived Dietary Patterns Are Associated with Colorectal Cancer Risk, Paige Miller; Philip Lazarus; Samuel Lesko; Joshua Muscat; Gregory R. Harper MD, PhD; Amanda Gross; Rashmi Sinha; Karen Ryczak; Gladys Escobar; David Mauger; and Terryl Hartman (Article)
Immunologic Therapy with Cadi-05 for the Treatment of Advanced Melanoma, Paul J. Mosca MD, PhD; Suresh G. Nair MD; Susan K. Ayre RN, MA; Wenjing Shi RN, MS; Sherrine Eid MPH; Shantu Amin PhD; Dhimant Desai PhD; Joseph J. Drabick MD, FACP; Bakulesh M. Khamar MD; Arati Sharma PhD; Svetomir N. Markovic MD; and Gavin P. Robertson PhD (Poster)
Adjuvant mFOLFOX6 plus or minus cetuximab (Cmab) in patients (pts) with KRAS mutant (m) resected stage III colon cancer (CC): NCCTG Intergroup Phase III Trial N0147, Suresh G. Nair MD; Richard M. Goldberg; Daniel J. Sargent; Stephen N. Thibodeau; Margaret R. Mahoney; Anthony F. Sheilds; Emily Chan; Sharlene Gill; Morton S. Kahlenberg; and Steven R. Alberts MD, MPH (Presentation)
Circulating tumor cells in colorectal cancer: past, present, and future challenges., Benjamin P Negin and Steven J Cohen (Article)
RB gene family: genome-wide ChIP approaches could open undiscovered roads., Flavio Rizzolio, Luca Esposito, Debora Muresu, Roberto S Fratamico MD, Ranna Jaraha, Gianluca Vosa Caprioli, and Antonio Giordano (Article)
Oxaliplatin resistance induced by ERCC1 up-regulation is abrogated by siRNA-mediated gene silencing in human colorectal cancer cells., Raviraja N Seetharam, Arjun Sood, Atrayee Basu-Mallick, Leonard H Augenlicht, John M Mariadason, and Sanjay Goel (Article)
Identification of Issues Faced by Cancer Survivors, Kathy Sevedge RN, MA, AOCN (Poster)
Patient Navigation: Past, Present and Future, Kathy Sevedge RN, MA, AOCN (Presentation)
Pancreatic adenocarcinoma., Margaret A Tempero, J Pablo Arnoletti, Stephen Behrman, Edgar Ben-Josef, Al B Benson, Jordan D Berlin, John L Cameron, Ephraim S Casper, Steven J Cohen, Michelle Duff, Joshua D I Ellenhorn, William G Hawkins, John P Hoffman, Boris W Kuvshinoff, Mokenge P Malafa, Peter Muscarella, Eric K Nakakura, Aaron R Sasson, Sarah P Thayer, Douglas S Tyler, Robert S Warren, Samuel Whiting, Christopher Willett, and Robert A Wolff (Article)
Testicular lymphoma., Lisa C Thomas, Christian Adonizio, Joanne Filicko-O'Hara, Ali R Golshayan, Luciano J Costa, and Gloria J Morris (Article)
Downregulation of Rap1GAP in human tumor cells alters cell/matrix and cell/cell adhesion., Oxana M Tsygankova, Changqing Ma, Waixing Tang, Christopher Korch, Michael D Feldman, Yu Lv, Marcia S Brose, and Judy L Meinkoth (Article)
2009
Training Tomorrow’s Providers and Expanding Access to Peginterferon/Ribavirin Combination Therapyfor Chronic Hepatatis C in Underinsured/Uninsured Patients: Final Outcomes of a Pilot, Resident-Initiated, Multidisciplinary, Hepatitis C Clinic, Nicole M. Agostino DO; Suzanne J. Templer DO; Edward Norris MD, FAPM; Charles M. Brooks MD; Eric J. Gertner MD, MPH; and Joseph L. Yozviak DO, FACP (Poster)
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas., Adam J Bass, Hideo Watanabe, Craig H Mermel, Soyoung Yu, Sven Perner, Roel G Verhaak, So Young Kim, Leslie Wardwell, Pablo Tamayo, Irit Gat-Viks, Alex H Ramos, Michele S Woo, Barbara A Weir, Gad Getz, Rameen Beroukhim, Michael O'Kelly, Amit Dutt, Orit Rozenblatt-Rosen, Piotr Dziunycz, Justin Komisarof, Lucian R Chirieac, Christopher J Lafargue, Veit Scheble, Theresia Wilbertz, Changqing Ma, Shilpa Rao, Hiroshi Nakagawa, Douglas B Stairs, Lin Lin, Thomas J Giordano, Patrick Wagner, John D Minna, Adi F Gazdar, Chang Qi Zhu, Marcia S Brose, Ivan Cecconello, Ulysses Ribeiro, Suely K Marie, Olav Dahl, Ramesh A Shivdasani, Ming-Sound Tsao, Mark A Rubin, Kwok K Wong, Aviv Regev, William C Hahn, David G Beer, Anil K Rustgi, and Matthew Meyerson (Article)
Thyroid cancer update: dramatic changes in the treatment of a rare disease., Marcia S Brose (Article)
Completion of a Phase II study of sorafenib for advanced thyroid cancer, M S. Brose (Article)
CHAPTER 92 - TRANSPLANT MEDICINE, Mark Chaballa, Joannee Filicko-O'Hara, Dorothy Holt, Adam M. Frank, John L. Wagner, Dolores Grosso, and Neal Flomenberg (Book Chapter)
Hypoxia influences CD40-CD40L mediated inflammation in endothelial and monocytic cells., Subrata Chakrabarti, Muhammad A. Rizvi MD, Didi Pathak, Michael T Kirber, and Jane E Freedman (Article)
Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer., S J Cohen, C J A Punt, N Iannotti, B H Saidman, K D Sabbath, N Y Gabrail, J Picus, M A Morse, E Mitchell, M C Miller, G V Doyle, H Tissing, L W M M Terstappen, and N J Meropol (Article)
Circulating tumor cells: evolving evidence and future challenges., Efrat Dotan, Steven J Cohen, Katherine R Alpaugh, and Neal J Meropol (Article)
Human Immunodeficiency Virus (HIV)-Associated Acute Myeloid Leukemia (AML) in the Era of Highly Active Antiretroviral Therapy (HAART): High Complete Remission Rate, but Poor Tolerance of Consolidation Therapy and Short Disease-Free Survival, Michael W. Evans MD, MPH (Article)